Pancreatic Cancer Research

ResearcherJiangsu Province HospitalNo recent work listed

Dongfang Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8801-2190; OpenAlex author ID A5084853102. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2018: 4 papers

Papers 4

  1. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway. Co-author DOI 10.1002/ijc.31173↗
  2. Long non-coding RNA lnc-PCTST predicts prognosis through inhibiting progression of pancreatic cancer by downregulation of TACC-3. Co-author DOI 10.1002/ijc.31657↗
  3. ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation. Co-author DOI 10.1159/000491915↗
  4. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regul… Co-author DOI 10.1186/s12943-018-0761-9↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zipeng Lu · 4 shared papers, 2018 · strength 0.29
  2. Hao Yuan · 4 shared papers, 2018 · strength 0.29
  3. Yi Miao · 4 shared papers, 2018 · strength 0.29
  4. Pengfei Wu · 3 shared papers, 2018 · strength 0.22
  5. Yuan Ming He · 3 shared papers, 2018 · strength 0.21
  6. Kuirong Jiang · 3 shared papers, 2018 · strength 0.21
  7. Guodong Shi · 3 shared papers, 2018 · strength 0.21
  8. Tianfang Xia · 2 shared papers, 2018 · strength 0.14
  9. Yandong Wang · 2 shared papers, 2018 · strength 0.14
  10. Hao Hu · 2 shared papers, 2018 · strength 0.14
  11. Yang Feng Wu · 1 shared paper, 2018 · strength 0.07
  12. Jian‐Min Chen · 1 shared paper, 2018 · strength 0.07
  13. Kuirong Jiang · 1 shared paper, 2018 · strength 0.07
  14. Pengfei Wu · 1 shared paper, 2018 · strength 0.07
  15. Baobao Cai · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.